Updates

The SynGAP Research Fund 501(c)(3) dba Cure SYNGAP1 announced a $108,867 grant to Dr. Michael Courtney and Dr. Li-Li Li at the Turku Bioscience Centre, University of Turku, Finland, to advance their research on SYNGAP1 missense variants. Their project seeks to better understand the functional impact of these mutations and explore drug repurposing as a potential therapeutic approach.

Dr. Courtney’s team will use advanced phenotyping techniques to assess how SYNGAP1 missense variants impact the protein’s interaction with key neuronal components, such as PSD95, which is crucial for synaptic function. The project will also evaluate repurposed drugs like Nortriptyline and Tanganil for their ability to restore normal protein function. This comprehensive approach could lead to new therapeutic strategies for patients with SYNGAP1-Related Disorders (SRD). >> Keep reading 

3MT award BioCity Turku bioinformatics cancer defence dissertation Elias Tillandz EU horizon experience ffgc funding news honoraries honorary doctorate IMMUNOCAP immunology INITIALISE Jenny and Antti Wihuri Foundation MALDI Imaging Mass Spectrometry Melanoma metabolomics Ministry of Education and Culture Multimedia NGS Nobel Prize Research Council of Finland reserach article results Science Communication sequencing suomen akatemia SYNGAP1 SynGAP Research Fund TET harjoittelu training Type 1 Diabetes